(MENAFN- Ameliorate Digital Consultancy)
The In-Vitro Diagnostics (IVD) Devices Market Report 2022 report provides the latest industry data and future industry trends. The report lists leading competitors and manufacturers in the In-Vitro Diagnostics (IVD) Devices industry and provides strategic industry insights and analysis of factors influencing the competitiveness of the market. The geographical scope of the In-Vitro Diagnostics (IVD) Devices market is studied. The forecast market information, SWOT analysis, market scenario, and feasibility study are the vital aspects analyzed in this report.
The in vitro diagnostics market is projected to reach USD 144.7 billion by 2028 from USD 115.8 billion in 2023, at a CAGR of 6.10%. To learn more about this report, request a free sample copy
Leading Players in the In-Vitro Diagnostics (IVD) Devices Market: BD, Abbott, Danaher, Hologic, BioMerieux, Cepheid, Quidel, Roche Diagnostics, Siemens Healthcare, Sysmex, BMP Medical, TUV Rheinland and other.
Latest News:
BD:
BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay BD (Becton, Dickinson and Company) a leading global medical technology company, and CerTest Biotec announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories.
Danaher:
MORE IVD CONSOLIDATION AS DANAHER ACQUIRES IRIS
IT'S THE LATEST BIG ACQUISITION among major in vitro diagnostics (IVD) companies. Iris International, Inc. , of Chatsworth, California, has agreed to be acquired by Danaher Corporation of Washington, DC.
Announced last month, Danaher will pay a reported $338 million for Iris and the deal is expected to close by year's end. Iris is a major player in automated urine microscopy and chemistry systems. It has placed 3,800 such systems in 50 countries and had revenue of $118.3 million for 2011.
The leading players of the In-Vitro Diagnostics (IVD) Devices industry, their market share, product portfolio, company profiles are covered in this report. The leading market players are analyzed based on production volume, gross margin, market value, and price structure. The competitive market scenario among In-Vitro Diagnostics (IVD) Devices players will help the industry aspirants in planning their strategies. The statistics offered in this report will be a precise and useful guide to shape business growth.
Global In-Vitro Diagnostics (IVD) Devices Market Segmentation:
Market Segmentation: By Application:
Clinical Laboratories
Diagnostic Centers
By Product Type:
Clinical Chemistry Analyser
Intravenous Medical Devices
Test Strips
Other
The reagents & consumables segment held the dominant share of the global market in 2023 due to the surge in usage of self-testing kits, POC tests, and several other advanced products in in-vitro diagnosis. The increased number of research & development activities for diagnosing several chronic diseases is one of the major factors propelling the demand for reagents & consumables. Furthermore, increased emphasis on early diagnosis in developed and emerging countries leads to the rising number of patients undergoing routine tests, contributing to the higher growth of the segment.
(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)
get special discount on the first purchase of this report:
Regional and Country-level Analysis:
The key regions covered in the In-Vitro Diagnostics (IVD) Devices market report are North America ,
Europe, Asia Pacific, Latin America, Middle East and Africa . It also covers
key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy,
Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia,
Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia,
U.A.E, etc.
The market in North America was valued at USD 35.92 billion in 2021 and is anticipated to continue to dominate the global market during the forecast period. Some of the prominent factors contributing to the region's highest share include the presence of major companies in the region, such as Abbott, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, and Danaher Corporation, along with adequate and favorable government regulations, well-established diagnostic infrastructure, and adoption of technologically advanced diagnostic techniques.
Europe is anticipated to be the second-most dominant region in terms of in vitro diagnostics market share. The market in Europe holds a significant share due to rising healthcare expenditure, well-established infrastructure, and a large pool of patients suffering from infectious diseases and cancer.
The market in Asia Pacific is estimated to grow at the highest CAGR, especially in developing countries such as India, South Korea, Australia, and China. Improving approval & reimbursement policies and rising per capita healthcare expenditure in this region are projected to drive the market growth in Asia Pacific during 2022-2029. For instance, in April 2021, Seegene Inc. announced that it secured an export permit from South Korea's Ministry of Food and Drug Safety to begin exporting its COVID-19 variant tests to countries worldwide. This permit will fortify the company's sales and market position globally.
Key questions answered in the report include:
What will the market size and the growth rate be in 2029? What are the key factors driving the Global In-Vitro Diagnostics (IVD) Devices Market? What are the key market trends impacting the growth of the Global In-Vitro Diagnostics (IVD) Devices Market? What are the challenges to market growth? Who are the key vendors in the Global In-Vitro Diagnostics (IVD) Devices Market? What are the market opportunities and threats faced by the vendors in the Global In-Vitro Diagnostics (IVD) Devices Market? Trending factors influencing the market shares of the Americas, APAC, Europe, and MEA. To know about the assumptions considered for the study, download the pdf brochure
Crucial Elements from the Table of Contents of Global In-Vitro Diagnostics (IVD) Devices Market:
– In-Vitro Diagnostics (IVD) Devices Market Overview
– Global In-Vitro Diagnostics (IVD) Devices Market Competition, Profiles/Analysis, Strategies
– Global In-Vitro Diagnostics (IVD) Devices Capacity, Production, Revenue (Value) by Region (2016-2022)
– Global In-Vitro Diagnostics (IVD) Devices Supply (Production), Consumption, Export, Import by Region (2016-2022)
– Global In-Vitro Diagnostics (IVD) Devices Market Regional Highlights
– Industrial Chain, Sourcing Strategy, and Downstream Buyers
– Marketing Strategy Analysis, Distributors/Traders
– Market Effect Factors Analysis
– Market Decisions for the present scenario
– Global In-Vitro Diagnostics (IVD) Devices Market Forecast (2022-2029)
– Case Studies
– Research Findings and Conclusion
Finally, the In-Vitro Diagnostics (IVD) Devices Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. The In-Vitro Diagnostics (IVD) Devices industry report additionally presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.
*If you need anything more than these then let us know and we will prepare the report according to your requirement...!
Customization services available with the report :
-20% customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-customization upto 40 hours.
-Post-sales support for 1 year from the date of delivery.
Contact Us:
Irfan Tamboli (Head of Sales) – Market Intelligence Data
Phone: + 1704 266 3234